A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.
Nadolol has been studied across 22 research domains including ❤️ Cardiovascular, 🫁 Liver & Detox, 🦠 Gut & Microbiome, 😴 Sleep, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 35% of studies addressing this area.
The following compounds share molecular targets with Nadolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Nadolol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.